About this trial
This feasibility randomized controlled trial will assess the acceptability, feasibility, and preliminary effects of an integrated mindfulness and exercise eHealth intervention, eMindExCare, among prostate cancer patients undergoing active treatment in Hong Kong. Participants will be randomized in a 1:1 ratio to either an 8-week eMindExCare intervention or an enhanced health education attention-control programme. eMindExCare integrates culturally adapted Cantonese mindfulness practices with home-based aerobic and resistance exercise delivered through Zoom, supported by home practice, exercise logs, and weekly reminders. The enhanced health education control programme will match the intervention group in contact time and engagement but will not include progressive aerobic training, resistance-band prescription, stationary bike provision, or a structured mindfulness curriculum. Feasibility and acceptability outcomes will include eligibility, consent, randomization, attendance, retention, questionnaire completion, missing data, and adverse events. Preliminary outcomes will include sleep quality, fatigue, pain, physical activity, mindfulness, motivation for exercise, and quality of life assessed at baseline, immediately post-intervention at week 8, and 3 months post-intervention.
Eligibility criteria
Qualifiers
Diagnosed with prostate cancer, stage I, II, or III.
Aged older than 18 years.
Undergoing active treatment, including chemotherapy, radiotherapy, or hormone therapy, at Prince of Wales Hospital.
Able to communicate and read Chinese.
Disqualifiers
Diagnosed with more than one primary cancer.
Has metastatic disease.
Has participated in a mindfulness programme.
Is sufficiently physically active at the time of recruitment.
Trial design
Treatments tested in this trial
- eMindExCare
- Enhanced Health Education
Treatment groups
Sponsors and collaborators
The University of Hong Kong
Lead sponsor
Chinese University of Hong Kong
Collaborator